These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16647061)

  • 1. Enzymatic activity of the SARS coronavirus main proteinase dimer.
    Graziano V; McGrath WJ; DeGruccio AM; Dunn JJ; Mangel WF
    FEBS Lett; 2006 May; 580(11):2577-83. PubMed ID: 16647061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS CoV main proteinase: The monomer-dimer equilibrium dissociation constant.
    Graziano V; McGrath WJ; Yang L; Mangel WF
    Biochemistry; 2006 Dec; 45(49):14632-41. PubMed ID: 17144656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations.
    Chen S; Chen L; Tan J; Chen J; Du L; Sun T; Shen J; Chen K; Jiang H; Shen X
    J Biol Chem; 2005 Jan; 280(1):164-73. PubMed ID: 15507456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses.
    Tan J; Verschueren KH; Anand K; Shen J; Yang M; Xu Y; Rao Z; Bigalke J; Heisen B; Mesters JR; Chen K; Shen X; Jiang H; Hilgenfeld R
    J Mol Biol; 2005 Nov; 354(1):25-40. PubMed ID: 16242152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase.
    Li C; Qi Y; Teng X; Yang Z; Wei P; Zhang C; Tan L; Zhou L; Liu Y; Lai L
    J Biol Chem; 2010 Sep; 285(36):28134-40. PubMed ID: 20489209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modeling of the SARS coronavirus main proteinase and conformational flexibility of the active site].
    Liu S; Pei J; Chen H; Zhu X; Liu Z; Ma W; He F; Lai L
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 May; 35 Suppl():62-5. PubMed ID: 12914221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer.
    Xu T; Ooi A; Lee HC; Wilmouth R; Liu DX; Lescar J
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Nov; 61(Pt 11):964-6. PubMed ID: 16511208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure.
    Hu T; Zhang Y; Li L; Wang K; Chen S; Chen J; Ding J; Jiang H; Shen X
    Virology; 2009 Jun; 388(2):324-34. PubMed ID: 19409595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.
    Zhu L; George S; Schmidt MF; Al-Gharabli SI; Rademann J; Hilgenfeld R
    Antiviral Res; 2011 Nov; 92(2):204-12. PubMed ID: 21854807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulations.
    Chen S; Hu T; Zhang J; Chen J; Chen K; Ding J; Jiang H; Shen X
    J Biol Chem; 2008 Jan; 283(1):554-564. PubMed ID: 17977841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.
    Lai L; Han X; Chen H; Wei P; Huang C; Liu S; Fan K; Zhou L; Liu Z; Pei J; Liu Y
    Curr Pharm Des; 2006; 12(35):4555-64. PubMed ID: 17168761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism.
    Huang C; Wei P; Fan K; Liu Y; Lai L
    Biochemistry; 2004 Apr; 43(15):4568-74. PubMed ID: 15078103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Only one protomer is active in the dimer of SARS 3C-like proteinase.
    Chen H; Wei P; Huang C; Tan L; Liu Y; Lai L
    J Biol Chem; 2006 May; 281(20):13894-8. PubMed ID: 16565086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery.
    Grum-Tokars V; Ratia K; Begaye A; Baker SC; Mesecar AD
    Virus Res; 2008 Apr; 133(1):63-73. PubMed ID: 17397958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease.
    Chou CY; Chang HC; Hsu WC; Lin TZ; Lin CH; Chang GG
    Biochemistry; 2004 Nov; 43(47):14958-70. PubMed ID: 15554703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.
    Anand K; Ziebuhr J; Wadhwani P; Mesters JR; Hilgenfeld R
    Science; 2003 Jun; 300(5626):1763-7. PubMed ID: 12746549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain.
    Shi J; Song J
    FEBS J; 2006 Mar; 273(5):1035-45. PubMed ID: 16478476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-range cooperative interactions modulate dimerization in SARS 3CLpro.
    Barrila J; Bacha U; Freire E
    Biochemistry; 2006 Dec; 45(50):14908-16. PubMed ID: 17154528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease.
    Wu CG; Cheng SC; Chen SC; Li JY; Fang YH; Chen YH; Chou CY
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):747-55. PubMed ID: 23633583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides.
    Du Q; Wang S; Jiang Z; Gao W; Li Y; Wei D; Chou KC
    Med Chem; 2005 May; 1(3):209-13. PubMed ID: 16787316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.